Trial Profile

Phase II randomized, double-masked, placebo-controlled Proof of concept clinical trial of PP-001 in patients with ocular surface inflammation due to dry eye disease

Status: Active, no longer recruiting

Phase of Trial: Phase I/II

Latest Information Update: 30 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

15 Nov 2021 According to an EyeGate Pharma media release, pre-IND meeting with the FDA in the first quarter of 2022 to confirm Phase 3b readiness in PRK surgery.
08 Sep 2021 Status changed from recruiting to active, no longer recruiting according to an EyeGate Pharma media release.
12 Aug 2021 According to a EyeGate Pharma media release, the company will hold a type B, pre-IND meeting with the USA FDA to discuss the path to initiating a Phase 2 clinical trial for patients with DED in Q3 2021.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com